Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06823700

Safety and Effectiveness Study of SQ-Kyrin System for Functional Mitral Regurgitation in EU

A Prospective, Multicenter, Single Arm Study to Evaluate the Safety and Effectiveness of Shenqi Transcatheter Mitral Valve Clips Delivery System and Steerable Guide Catheters in Patients with Functional Mitral Regurgitation

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
34 (estimated)
Sponsor
Shanghai Shenqi Medical Technology Co., Ltd · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The investigation objective of this study is to evaluate the safety and effectiveness of the Transcatheter Mitral Valve Clip Delivery System and Steerable Guide Catheter in the population of FMR patients and the accessories devices when used in conjunction with the Transcatheter Mitral Valve Clip Delivery System and Steerable Guide Catheter.

Detailed description

The primary objective is to verify the safety and effectiveness of the Transcatheter Mitral Valve Clip Delivery System and Steerable Guide Catheter produced by Shanghai Shenqi Medical Technology Co., Ltd. In the treatment of patients with moderate-severe (3 +) or severe (4 +) FMR whose symptoms and MR severity persist despite maximally tolerated GDMT as determined by a multidisciplinary heart team experienced in the evaluation and treatment of heart failure and mitral valve disease.

Conditions

Interventions

TypeNameDescription
DEVICESQ-Kyrin Transcatheter Mitral Valve Repair SystemTo percutaneously repair the mitral valve via the femoral vein and atrial septum, offering a treatment for symptomatic functional mitral regurgitation through edge-to-edge valve clipping.

Timeline

Start date
2024-12-17
Primary completion
2026-12-31
Completion
2026-12-31
First posted
2025-02-12
Last updated
2025-02-12

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT06823700. Inclusion in this directory is not an endorsement.